Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide. - Wikidata - awgldk - TriplyDB

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

http://www.wikidata.org/entity/Q37688125

about

Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.Semaphorin 3C and Its Receptors in Cancer and Cancer Stem-Like Cells.Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues

P2860

Q49544289-16FB3FC7-D9E6-46BA-ABD3-EE9058278DCA Q55457324-9E833383-D70C-42E8-AA87-3B8BDA2D4B79 Q57176391-4CDC7235-4CE1-461E-BCE0-EC1E5ABCE03F

P2860

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

http://www.wikidata.org/entity/Q37688125

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of primary breast t ...... ne domain interfering peptide.

@en

Inhibition of primary breast t ...... ne domain interfering peptide.

@nl

type

label

Inhibition of primary breast t ...... ne domain interfering peptide.

@en

Inhibition of primary breast t ...... ne domain interfering peptide.

@nl

prefLabel

Inhibition of primary breast t ...... ne domain interfering peptide.

@en

Inhibition of primary breast t ...... ne domain interfering peptide.

@nl

P1433

Q37688125-6261D599-8D8E-49F9-BC1F-E7764262127E

P1476

Q37688125-01E49742-3630-4C7F-9DB5-8C2263971E2F

P2093

Q37688125-1A133C80-FA40-407A-BFA8-B74F56A5E344

Q37688125-21925B9C-EACA-4F25-AB4E-941EDA0221AF

Q37688125-2C8924BC-E9A7-4DD9-A014-203FA6038298

Q37688125-794ACCEF-2A78-457B-8746-DB44A459EAB1

Q37688125-97C2D627-BE5C-4EB8-A246-A469CE99D140

Q37688125-D063AC42-EF4A-40D0-A6A2-B921989D39D3

Q37688125-DF07EEFF-6EFE-4332-8797-A9BC90699C1C

P2860

Q37688125-010E5855-C47E-4525-97D9-733F8BCBB2E4

Q37688125-01673FCD-0D0A-4F3B-B693-8C70A879032D

Q37688125-01D35658-414C-4BA5-863C-E4A71C801EFF

Q37688125-158BB3DC-E717-40C8-9313-DB70C2817927

Q37688125-19F85C3B-573E-4759-BBAE-8797262111E3

Q37688125-35BF6392-17B2-4ABF-A7D7-897F1C053B02

Q37688125-5EA71DC9-C1DF-467A-953D-BA9C21686039

Q37688125-615AC341-449E-472A-BBC3-46514776316A

Q37688125-66FA7682-05D6-49E6-9EA5-922DE2873FCF

Q37688125-68C8D974-EE18-413D-BFC3-1124492AAAF3

P304

Q37688125-3EA71F6D-A5F1-4C90-9B59-74446F297B7C

P31

Q37688125-0CAF2BE7-636E-4EBC-B6E6-ABD2D146FA5A

P356

Q37688125-9F3773DB-53EE-4A2B-BCAF-9A070D752B40

P407

Q37688125-20FD2D43-A433-4148-AA21-B3FF80664EEF

P433

Q37688125-710B8507-C837-4D8A-9690-8CF1BE08424A

P478

Q37688125-55A4F7D2-0D97-4FC1-8745-CDF72801EC23

P50

Q37688125-22BB1259-E67E-4A91-8BA2-67C841F4ABD5

Q37688125-884EF738-7BB9-4A8F-9FA9-0AC78E864BB3

Q37688125-AFD66A56-A127-4F5A-BFD3-783A67962AC8

P577

Q37688125-ACB62D92-957B-484D-A137-F7A5694AF7E5

P698

Q37688125-068F2C24-5AD0-4C5A-8AD8-6FC82ACDF126

P921

Q37688125-19A827C6-C79D-42F5-AB83-5F2878329702

P932

Q37688125-C13C6C89-1DC3-4C85-98BB-F6907C402907

P356

ONCOTARGET.10101

P1433

P1476

Inhibition of primary breast t ...... ane domain interfering peptide

@en

P2093

Alexia Arpel

http://www.w3.org/2001/XMLSchema#string

Aurore Fernandez

http://www.w3.org/2001/XMLSchema#string

Coralie Gamper

http://www.w3.org/2001/XMLSchema#string

Gertraud Orend

http://www.w3.org/2001/XMLSchema#string

Gérard Crémel

http://www.w3.org/2001/XMLSchema#string

Nadège Baumlin

http://www.w3.org/2001/XMLSchema#string

Patrice Laquerriere

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Transmembrane recognition of the semaphorin co-receptors neuropilin 1 and plexin A1: coarse-grained simulations

A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells

Dissemination and growth of cancer cells in metastatic sites

Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance.

Mammary developmental fate and breast cancer risk.

Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models

Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.

P304

54723-54732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10101

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Bagnard

Caroline Spenlé

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27351129

http://www.w3.org/2001/XMLSchema#string

P921

transmembrane protein

P932

5342376

http://www.w3.org/2001/XMLSchema#string